136.01
price up icon1.21%   1.63
pre-market  Pre-market:  136.01  
loading
Abbott Laboratories stock is traded at $136.01, with a volume of 5.75M. It is up +1.21% in the last 24 hours and up +1.82% over the past month. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$134.38
Open:
$134
24h Volume:
5.75M
Relative Volume:
0.88
Market Cap:
$233.36B
Revenue:
$42.34B
Net Income/Loss:
$13.50B
P/E Ratio:
17.64
EPS:
7.71
Net Cash Flow:
$6.66B
1W Performance:
+2.06%
1M Performance:
+1.82%
6M Performance:
+20.25%
1Y Performance:
+30.89%
1-Day Range:
Value
$134.00
$136.26
1-Week Range:
Value
$132.38
$139.06
52-Week Range:
Value
$99.71
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
Name
Abbott Laboratories
Name
Phone
(224) 667-6100
Name
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Employee
114,000
Name
Twitter
@AbbottNews
Name
Next Earnings Date
2025-04-16
Name
Latest SEC Filings
Name
ABT's Discussions on Twitter

Compare ABT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
ABT
Abbott Laboratories
136.01 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
107.41 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.63 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.17 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.21 44.46B 5.54B 4.18B 623.10M 7.00

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-16-25 Initiated Leerink Partners Market Perform
Oct-08-24 Initiated Oppenheimer Outperform
Sep-19-24 Initiated Piper Sandler Overweight
Jul-30-24 Downgrade Edward Jones Buy → Hold
May-30-24 Initiated Goldman Buy
Jul-21-23 Upgrade Wolfe Research Underperform → Peer Perform
May-30-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-20-23 Reiterated Barclays Overweight
Apr-20-23 Reiterated Bernstein Outperform
Apr-20-23 Reiterated JP Morgan Overweight
Apr-20-23 Reiterated Raymond James Outperform
Apr-20-23 Reiterated UBS Buy
Apr-20-23 Reiterated Wolfe Research Underperform
Mar-29-23 Initiated UBS Buy
Oct-26-22 Initiated Mizuho Neutral
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Hold
Jul-06-22 Initiated Wolfe Research Underperform
Mar-02-22 Resumed BofA Securities Buy
Jan-27-22 Reiterated Credit Suisse Outperform
Jan-27-22 Reiterated Morgan Stanley Overweight
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated UBS Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Oct-27-21 Upgrade Atlantic Equities Neutral → Overweight
Oct-14-21 Initiated Redburn Neutral
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Jan-28-21 Upgrade BTIG Research Neutral → Buy
Sep-11-20 Initiated Wolfe Research Outperform
Jun-01-20 Downgrade Goldman Neutral → Sell
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-02-20 Downgrade Guggenheim Buy → Neutral
Jun-13-19 Reiterated BofA/Merrill Buy
Feb-07-19 Reiterated BofA/Merrill Buy
Jan-02-19 Downgrade Citigroup Neutral → Sell
Nov-30-18 Upgrade Goldman Neutral → Buy
Oct-16-18 Initiated Barclays Overweight
Jun-27-18 Initiated Bernstein Outperform
Jan-30-18 Reiterated Citigroup Neutral
Jan-25-18 Reiterated Stifel Buy
Jan-25-18 Upgrade William Blair Mkt Perform → Outperform
Jan-03-18 Initiated Evercore ISI Outperform
Jan-02-18 Upgrade JP Morgan Neutral → Overweight
Jan-02-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-19-17 Reiterated RBC Capital Mkts Outperform
Oct-19-17 Reiterated Stifel Buy
View All

Abbott Laboratories Stock (ABT) Latest News

pulisher
Jun 18, 2025

India Medical Nutrition Market Future Trends and Scope Analysis - openPR.com

Jun 18, 2025
pulisher
Jun 18, 2025

Abbott, MSD Forge Diabetes‑Drug Pact For Wider Indian Reach - BW Healthcare World

Jun 18, 2025
pulisher
Jun 18, 2025

Abbott Labs stock price target maintained at $140 by Oppenheimer - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Leerink Partners Begins Coverage on ABT - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

10 Best Dividend Stocks to Buy for Dependable Dividend Growth - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Who Rules Homecare Clinical Nutrition Market? Abbott, Danone, - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

Health Canada approves Abbott’s i-STAT TBI test for suspected concussions - Medical Device Network

Jun 17, 2025
pulisher
Jun 17, 2025

Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent

Jun 17, 2025
pulisher
Jun 16, 2025

Abbott (ABT) Stock Dips While Market Gains: Key Facts - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

Eaton makes a move outside of the data center — plus, what's new with Abbott Labs - CNBC

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Wins Dismissal of Whistleblower’s Medicare Fraud Suit - Bloomberg Law News

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Declares 406th Consecutive Quarterly Dividend - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Laboratories' Whole Blood Concussion Test Approved by Health Canada - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions - Barchart.com

Jun 16, 2025
pulisher
Jun 16, 2025

Blood Screening Market Outlook | Key Players: Abbott Laboratories, Roche, Grifols, BioMérieux - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Deep Venous Disease Treatment Market Key Players Analysis - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

1 Unpopular Stock that Should Get More Attention and 2 to Avoid - FinancialContent

Jun 16, 2025
pulisher
Jun 15, 2025

Jim Cramer Calls Abbott “Really Excellent” - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

Electrophysiology Devices Market Share Leaders: Abbott, Acutus Medical, and Biosense Webster - openPR.com

Jun 14, 2025
pulisher
Jun 13, 2025

Abbott Laboratories (ABT) Maintains Quarterly Dividend of $0.59 - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Declares 406Th Consecutive Quarterly Dividend, Payable on August 15, 2025 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Laboratories Keeps Quarterly Dividend at $0.59 per Share, Payable August 15 to Shareholders as of July 15 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Clinical Immunochemistry Analyzers Market projected reach USD 6.9 billion by 2034, growing at a CAGR of 4.4% | Exactitude Consultancy - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 12, 2025

Abbott Laboratories Stock Sees RS Rating Rise To 82 - Investor's Business Daily

Jun 12, 2025
pulisher
Jun 12, 2025

Stocks To Watch: Abbott Laboratories Sees RS Rating Rise To 82 - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Abbott and Medtronic best positioned manufacturers in US neurology market - PharmaLive

Jun 12, 2025
pulisher
Jun 11, 2025

Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive

Jun 10, 2025
pulisher
Jun 10, 2025

Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

3 Low-Volatility Stocks in Hot Water - FinancialContent

Jun 10, 2025
pulisher
Jun 09, 2025

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector? - MSN

Jun 09, 2025
pulisher
Jun 06, 2025

Abbott Laboratories (ABT) Stock Dips Slightly on NYSE, Long-Term Gains Remain Solid - Daily Chhattisgarh News

Jun 06, 2025
pulisher
Jun 05, 2025

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Thousands of lawsuits over baby formula should stay where filed, court says - Reuters

Jun 04, 2025
pulisher
Jun 04, 2025

Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Jun 04, 2025
pulisher
Jun 02, 2025

Test Strip Market Is Booming So Rapidly 2025-2032 -Abbott - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System - insights.citeline.com

Jun 02, 2025
pulisher
Jun 02, 2025

Abbott Laboratories Stock: Is ABT Outperforming The Health Care Sector? - Barchart.com

Jun 02, 2025
pulisher
Jun 02, 2025

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $153 From $147, Maintains Buy Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 01, 2025

There's Been No Shortage Of Growth Recently For Abbott Laboratories' (NYSE:ABT) Returns On Capital - Yahoo Finance

Jun 01, 2025
pulisher
May 30, 2025

Abbott Tendyne TMVR secures FDA clearance - BioWorld MedTech

May 30, 2025
pulisher
May 30, 2025

Cardiac Marker Analyzer Market Is Booming WorldwideAbbott, Roche Diagnostics - openPR.com

May 30, 2025
pulisher
May 30, 2025

Abbott Labs (ABT) Stock Ticks Lower: Gauging the Pulse and Future Price Points - Daily Chhattisgarh News

May 30, 2025

Abbott Laboratories Stock (ABT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices BSX
$107.41
price up icon 0.83%
medical_devices SYK
$395.63
price up icon 0.53%
medical_devices MDT
$87.17
price up icon 1.34%
medical_devices EW
$78.21
price up icon 0.00%
$74.07
price down icon 0.42%
Cap:     |  Volume (24h):